Agenda
Day 1 — Main Conference
June 16, 2020
8:30 am
Registration and Networking
9:00 am
Opening Remarks from the Conference Chair
9:10 am
Year in Review
Analysing Key Legal Developments and Determining if SPCs are Still Fit for Their Purpose
10:30 am
Networking and Refreshments
11:00 am
Handling SPCs Based on Secondary Medical Use Applications
12:15 pm
Lunch and Networking
1:15 pm
“Protection by a Basic Patent in Force”: Pending Referrals on Art. 3(a) Requirements
2:30 pm
Analysing the Complications of Two-Part Teva Test and Its Implications for Compound Patents
3:30 pm
Networking and Refreshments
4:00 pm
National Patent Offices Speak on Overcoming Disparities of Protection in Europe
5:15 pm
Chair’s Summary: Key Takeaways From Day 1
5:30 pm
Conference Adjourns
Day 2 — Main Conference
June 17, 2020
9:00 am
Opening Remarks from the Conference Chair
9:15 am
Keynote Presentation
9:45 am
SPC Waiver (EU) 2019/933: Assessing the Impact of the Manufacturing Waiver One Year After Inception
10:45 am
Networking and Refreshments
11:15 am
Evaluating SPC eligibility in Non-Traditional and Novel Scenarios
12:30 pm
Lunch and Networking
1:30 pm
Seeking SPC Terms based on Third Party Marketing Authorisation (MA)
2:30 pm
Maximising Paediatric Exclusivity: Study of the Recent Swiss Experience
3:00 pm
Networking and Refreshments
3:30 pm
Securing and Extending Data Exclusivity While Staying Compliant with the Latest Transparency Rules and Regulations
4:15 pm
Chair’s Closing Remarks
4:30 pm